HEADER GENE REGULATION 14-JAN-21 7LEL TITLE CRYSTAL STRUCTURE OF THE SECOND BROMODOMAIN (BD2) OF HUMAN BRDT BOUND TITLE 2 TO BROMOSPORINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: BROMODOMAIN TESTIS-SPECIFIC PROTEIN; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: CANCER/TESTIS ANTIGEN 9,CT9,RING3-LIKE PROTEIN; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRDT; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS BRDT, BET, PLK1, TESTIS SPECIFIC, BROMODOMAIN, GENE REGULATION EXPDTA X-RAY DIFFRACTION AUTHOR A.CHAN,M.R.KARIM,E.SCHONBRUNN REVDAT 5 25-DEC-24 7LEL 1 REMARK LINK REVDAT 4 18-OCT-23 7LEL 1 REMARK REVDAT 3 24-NOV-21 7LEL 1 JRNL REVDAT 2 17-NOV-21 7LEL 1 JRNL REVDAT 1 14-JUL-21 7LEL 0 JRNL AUTH R.M.KARIM,M.J.BIKOWITZ,A.CHAN,J.Y.ZHU,D.GRASSIE,A.BECKER, JRNL AUTH 2 N.BERNDT,S.GUNAWAN,N.J.LAWRENCE,E.SCHONBRUNN JRNL TITL DIFFERENTIAL BET BROMODOMAIN INHIBITION BY JRNL TITL 2 DIHYDROPTERIDINONE AND PYRIMIDODIAZEPINONE KINASE JRNL TITL 3 INHIBITORS. JRNL REF J.MED.CHEM. V. 64 15772 2021 JRNL REFN ISSN 0022-2623 JRNL PMID 34710325 JRNL DOI 10.1021/ACS.JMEDCHEM.1C01096 REMARK 2 REMARK 2 RESOLUTION. 2.15 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.13_2998 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.15 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 56.20 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.980 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.4 REMARK 3 NUMBER OF REFLECTIONS : 28670 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.185 REMARK 3 R VALUE (WORKING SET) : 0.183 REMARK 3 FREE R VALUE : 0.232 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.500 REMARK 3 FREE R VALUE TEST SET COUNT : 1004 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 56.1990 - 4.1124 0.97 4000 146 0.1472 0.1651 REMARK 3 2 4.1124 - 3.2642 0.97 4013 145 0.1655 0.2284 REMARK 3 3 3.2642 - 2.8516 0.97 4013 146 0.2056 0.2801 REMARK 3 4 2.8516 - 2.5909 0.96 3964 144 0.2096 0.2273 REMARK 3 5 2.5909 - 2.4052 0.95 3902 141 0.2157 0.2948 REMARK 3 6 2.4052 - 2.2634 0.94 3885 141 0.2212 0.2967 REMARK 3 7 2.2634 - 2.1500 0.94 3889 141 0.2360 0.3223 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.270 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.820 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 29.99 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 38.28 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): -25.9313 -7.2059 -38.2494 REMARK 3 T TENSOR REMARK 3 T11: 0.2333 T22: 0.2396 REMARK 3 T33: 0.2455 T12: 0.0105 REMARK 3 T13: 0.0051 T23: -0.0030 REMARK 3 L TENSOR REMARK 3 L11: 0.5075 L22: 0.3010 REMARK 3 L33: 0.4058 L12: 0.0359 REMARK 3 L13: 0.1850 L23: -0.3261 REMARK 3 S TENSOR REMARK 3 S11: 0.0053 S12: 0.0066 S13: 0.0100 REMARK 3 S21: -0.0147 S22: 0.0085 S23: 0.0060 REMARK 3 S31: 0.0125 S32: -0.0142 S33: -0.0176 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7LEL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-JAN-21. REMARK 100 THE DEPOSITION ID IS D_1000253741. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-APR-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9700 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28678 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.150 REMARK 200 RESOLUTION RANGE LOW (A) : 56.199 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.3 REMARK 200 DATA REDUNDANCY : 3.849 REMARK 200 R MERGE (I) : 0.08500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.7700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.15 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.21 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.7 REMARK 200 DATA REDUNDANCY IN SHELL : 3.87 REMARK 200 R MERGE FOR SHELL (I) : 0.58500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.740 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5VBQ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.69 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.60 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.05 M CACL2, 2H2O, 0.1 M BIS-TRIS (PH REMARK 280 6.5), AND 30 % V/V PEG MME 550, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 262 REMARK 465 ALA A 263 REMARK 465 ALA A 264 REMARK 465 GLY B 262 REMARK 465 ALA B 263 REMARK 465 ALA B 264 REMARK 465 GLY C 262 REMARK 465 ALA C 263 REMARK 465 ALA C 264 REMARK 465 GLY D 262 REMARK 465 ALA D 263 REMARK 465 ALA D 264 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 ND2 ASN D 297 C06 BMF D 401 1.45 REMARK 500 OE2 GLU A 271 O HOH A 501 2.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR B 266 134.33 78.59 REMARK 500 REMARK 500 REMARK: NULL DBREF 7LEL A 266 378 UNP Q58F21 BRDT_HUMAN 266 378 DBREF 7LEL B 266 378 UNP Q58F21 BRDT_HUMAN 266 378 DBREF 7LEL C 266 378 UNP Q58F21 BRDT_HUMAN 266 378 DBREF 7LEL D 266 378 UNP Q58F21 BRDT_HUMAN 266 378 SEQADV 7LEL GLY A 262 UNP Q58F21 EXPRESSION TAG SEQADV 7LEL ALA A 263 UNP Q58F21 EXPRESSION TAG SEQADV 7LEL ALA A 264 UNP Q58F21 EXPRESSION TAG SEQADV 7LEL SER A 265 UNP Q58F21 EXPRESSION TAG SEQADV 7LEL GLY B 262 UNP Q58F21 EXPRESSION TAG SEQADV 7LEL ALA B 263 UNP Q58F21 EXPRESSION TAG SEQADV 7LEL ALA B 264 UNP Q58F21 EXPRESSION TAG SEQADV 7LEL SER B 265 UNP Q58F21 EXPRESSION TAG SEQADV 7LEL GLY C 262 UNP Q58F21 EXPRESSION TAG SEQADV 7LEL ALA C 263 UNP Q58F21 EXPRESSION TAG SEQADV 7LEL ALA C 264 UNP Q58F21 EXPRESSION TAG SEQADV 7LEL SER C 265 UNP Q58F21 EXPRESSION TAG SEQADV 7LEL GLY D 262 UNP Q58F21 EXPRESSION TAG SEQADV 7LEL ALA D 263 UNP Q58F21 EXPRESSION TAG SEQADV 7LEL ALA D 264 UNP Q58F21 EXPRESSION TAG SEQADV 7LEL SER D 265 UNP Q58F21 EXPRESSION TAG SEQRES 1 A 117 GLY ALA ALA SER THR VAL LYS VAL THR GLU GLN LEU ARG SEQRES 2 A 117 HIS CYS SER GLU ILE LEU LYS GLU MET LEU ALA LYS LYS SEQRES 3 A 117 HIS PHE SER TYR ALA TRP PRO PHE TYR ASN PRO VAL ASP SEQRES 4 A 117 VAL ASN ALA LEU GLY LEU HIS ASN TYR TYR ASP VAL VAL SEQRES 5 A 117 LYS ASN PRO MET ASP LEU GLY THR ILE LYS GLU LYS MET SEQRES 6 A 117 ASP ASN GLN GLU TYR LYS ASP ALA TYR LYS PHE ALA ALA SEQRES 7 A 117 ASP VAL ARG LEU MET PHE MET ASN CYS TYR LYS TYR ASN SEQRES 8 A 117 PRO PRO ASP HIS GLU VAL VAL THR MET ALA ARG MET LEU SEQRES 9 A 117 GLN ASP VAL PHE GLU THR HIS PHE SER LYS ILE PRO ILE SEQRES 1 B 117 GLY ALA ALA SER THR VAL LYS VAL THR GLU GLN LEU ARG SEQRES 2 B 117 HIS CYS SER GLU ILE LEU LYS GLU MET LEU ALA LYS LYS SEQRES 3 B 117 HIS PHE SER TYR ALA TRP PRO PHE TYR ASN PRO VAL ASP SEQRES 4 B 117 VAL ASN ALA LEU GLY LEU HIS ASN TYR TYR ASP VAL VAL SEQRES 5 B 117 LYS ASN PRO MET ASP LEU GLY THR ILE LYS GLU LYS MET SEQRES 6 B 117 ASP ASN GLN GLU TYR LYS ASP ALA TYR LYS PHE ALA ALA SEQRES 7 B 117 ASP VAL ARG LEU MET PHE MET ASN CYS TYR LYS TYR ASN SEQRES 8 B 117 PRO PRO ASP HIS GLU VAL VAL THR MET ALA ARG MET LEU SEQRES 9 B 117 GLN ASP VAL PHE GLU THR HIS PHE SER LYS ILE PRO ILE SEQRES 1 C 117 GLY ALA ALA SER THR VAL LYS VAL THR GLU GLN LEU ARG SEQRES 2 C 117 HIS CYS SER GLU ILE LEU LYS GLU MET LEU ALA LYS LYS SEQRES 3 C 117 HIS PHE SER TYR ALA TRP PRO PHE TYR ASN PRO VAL ASP SEQRES 4 C 117 VAL ASN ALA LEU GLY LEU HIS ASN TYR TYR ASP VAL VAL SEQRES 5 C 117 LYS ASN PRO MET ASP LEU GLY THR ILE LYS GLU LYS MET SEQRES 6 C 117 ASP ASN GLN GLU TYR LYS ASP ALA TYR LYS PHE ALA ALA SEQRES 7 C 117 ASP VAL ARG LEU MET PHE MET ASN CYS TYR LYS TYR ASN SEQRES 8 C 117 PRO PRO ASP HIS GLU VAL VAL THR MET ALA ARG MET LEU SEQRES 9 C 117 GLN ASP VAL PHE GLU THR HIS PHE SER LYS ILE PRO ILE SEQRES 1 D 117 GLY ALA ALA SER THR VAL LYS VAL THR GLU GLN LEU ARG SEQRES 2 D 117 HIS CYS SER GLU ILE LEU LYS GLU MET LEU ALA LYS LYS SEQRES 3 D 117 HIS PHE SER TYR ALA TRP PRO PHE TYR ASN PRO VAL ASP SEQRES 4 D 117 VAL ASN ALA LEU GLY LEU HIS ASN TYR TYR ASP VAL VAL SEQRES 5 D 117 LYS ASN PRO MET ASP LEU GLY THR ILE LYS GLU LYS MET SEQRES 6 D 117 ASP ASN GLN GLU TYR LYS ASP ALA TYR LYS PHE ALA ALA SEQRES 7 D 117 ASP VAL ARG LEU MET PHE MET ASN CYS TYR LYS TYR ASN SEQRES 8 D 117 PRO PRO ASP HIS GLU VAL VAL THR MET ALA ARG MET LEU SEQRES 9 D 117 GLN ASP VAL PHE GLU THR HIS PHE SER LYS ILE PRO ILE HET BMF A 401 28 HET BMF B 401 28 HET BMF C 401 28 HET BMF D 401 28 HETNAM BMF BROMOSPORINE HETSYN BMF ETHYL (3-METHYL-6-{4-METHYL-3-[(METHYLSULFONYL) HETSYN 2 BMF AMINO]PHENYL}[1,2,4]TRIAZOLO[4,3-B]PYRIDAZIN-8-YL) HETSYN 3 BMF CARBAMATE FORMUL 5 BMF 4(C17 H20 N6 O4 S) FORMUL 9 HOH *98(H2 O) HELIX 1 AA1 THR A 266 LEU A 284 1 19 HELIX 2 AA2 ALA A 285 LYS A 287 5 3 HELIX 3 AA3 HIS A 288 TRP A 293 1 6 HELIX 4 AA4 PRO A 294 TYR A 296 5 3 HELIX 5 AA5 ASP A 300 GLY A 305 1 6 HELIX 6 AA6 ASN A 308 VAL A 313 1 6 HELIX 7 AA7 ASP A 318 ASN A 328 1 11 HELIX 8 AA8 ASP A 333 ASN A 352 1 20 HELIX 9 AA9 HIS A 356 SER A 374 1 19 HELIX 10 AB1 THR B 266 LEU B 284 1 19 HELIX 11 AB2 ALA B 285 LYS B 287 5 3 HELIX 12 AB3 HIS B 288 TRP B 293 1 6 HELIX 13 AB4 PRO B 294 TYR B 296 5 3 HELIX 14 AB5 ASP B 300 GLY B 305 1 6 HELIX 15 AB6 ASN B 308 VAL B 313 1 6 HELIX 16 AB7 ASP B 318 ASN B 328 1 11 HELIX 17 AB8 ASP B 333 ASN B 352 1 20 HELIX 18 AB9 HIS B 356 SER B 374 1 19 HELIX 19 AC1 THR C 266 LEU C 284 1 19 HELIX 20 AC2 ALA C 285 LYS C 287 5 3 HELIX 21 AC3 HIS C 288 TRP C 293 1 6 HELIX 22 AC4 PRO C 294 TYR C 296 5 3 HELIX 23 AC5 ASP C 300 GLY C 305 1 6 HELIX 24 AC6 ASN C 308 VAL C 313 1 6 HELIX 25 AC7 ASP C 318 ASN C 328 1 11 HELIX 26 AC8 ASP C 333 ASN C 352 1 20 HELIX 27 AC9 HIS C 356 SER C 374 1 19 HELIX 28 AD1 THR D 266 ALA D 285 1 20 HELIX 29 AD2 HIS D 288 TRP D 293 1 6 HELIX 30 AD3 PRO D 294 TYR D 296 5 3 HELIX 31 AD4 ASP D 300 GLY D 305 1 6 HELIX 32 AD5 ASN D 308 VAL D 313 1 6 HELIX 33 AD6 ASP D 318 ASN D 328 1 11 HELIX 34 AD7 ASP D 333 ASN D 352 1 20 HELIX 35 AD8 HIS D 356 SER D 374 1 19 CRYST1 45.990 58.460 60.770 72.58 71.28 70.62 P 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021744 -0.007650 -0.005855 0.00000 SCALE2 0.000000 0.018133 -0.004008 0.00000 SCALE3 0.000000 0.000000 0.017794 0.00000